SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000895345-24-000039
Filing Date
2024-02-09
Accepted
2024-02-09 16:00:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 ff3004412_13ga2-satter.htm SC 13G/A 57325
  Complete submission text file 0000895345-24-000039.txt   58673
Mailing Address C/O SATTER INVESTMENT MANAGEMENT, LLC 676 NORTH MICHIGAN AVENUE, SUITE 4000 CHICAGO IL 60611
Business Address
Satter Muneer A (Filed by) CIK: 0001315797 (see all company filings)

Type: SC 13G/A

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Subject) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88058 | Film No.: 24614619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)